Features | Partner Sites | Information | LinkXpress
Sign In
SEEGENE
AB Sciex
RANDOX LABORATORIES

Molecular Detection Kit Assessed for African Trypanosomiasis

By Labmedica International staff writers
Posted on 31 Oct 2013
Image: Loopamp Realtime Turbidimeter for Loop-mediated Isothermal Amplification (Photo courtesy of Eiken Chemical).
Image: Loopamp Realtime Turbidimeter for Loop-mediated Isothermal Amplification (Photo courtesy of Eiken Chemical).
Molecular methods have great potential for sensitive parasite detection in the diagnosis of human African trypanosomiasis (HAT), but the requirements in terms of laboratory infrastructure limit their use to reference centers.

A recently develop commercial assay that uses loop mediated isothermal amplification (LAMP) has been transformed into a ready-to-use kit format that does not require thermocyclers and amplification and can be conducted in a heating block or a hot water bath.

Tropical medicine specialists at the Institute of Tropical Medicine (Antwerp, Belgium) working with colleagues at the Kinshasa University (Kinshasa, Democratic Republic of the Congo) evaluated the diagnostic performance of the Loopamp Trypanosoma brucei assay (LAMP) in confirmed T.b. gambiense HAT patients, HAT suspects and healthy endemic controls from the Democratic Republic of the Congo (DRC).

Archived DNA from blood samples from 142 T. b. gambiense HAT patients, 111 healthy endemic controls and 97 HAT suspects with unconfirmed status were included in a retrospective evaluation. The Loopamp Trypanosoma brucei Detection Kit (Eiken Chemical; Tokyo, Japan) was applied in duplicate on the DNA extracts. LAMP amplified T. brucei DNA was visualized using the provided ultraviolet-light emitted diode (UV-LED) device. Amplified DNA emits green fluorescence while there is no fluorescence in negative samples.

Of the 142 HAT patients, 132 and 124 were LAMP positive in respectively the first and second run, corresponding with sensitivities of 93.0% and 87.3%. Of the 11 patients with trypanosomes detected only in lymph or in cerebral spinal fluid (CSF), seven were positive in both LAMP runs on blood. Of the 97 HAT suspects, six were positive in both replicates of LAMP, eight and 20 were positive in the first and second replicate, respectively. Of 111 healthy endemic controls, four tested positive twice with LAMP and four tested positive only once.

The authors concluded that the LAMP has similar diagnostic accuracy as the 18S ribosomal DNA (rDNA) polymerase chain reaction (PCR) and can replace PCR for accurate and simplified detection of Trypanozoon DNA in clinical specimens. LAMP showed good diagnostic accuracy and excellent reproducibility, and may have an important role to play in disease surveillance. However, it should be noted that the specificity of LAMP is not 100%, that HAT treatment is complex and toxic, and that the positive predictive value of tests is low in hypoendemic settings. The study was published on October 17, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Institute of Tropical Medicine
Kinshasa University 
Eiken Chemical 



GREINER-BIO-ONE
ADVANCED INSTRUMENTS
PURITAN MEDICAL
BioConferenceLive

Channels

Genetic Tests

view channel
Image: The QuantiTect Reverse Transcription Kit (Photo courtesy of Qiagen)

Blood Tests Predict Risk of Sudden Cardiac Death

A simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to quickly and accurately assess a patient's need for an implantable cardiac defibrillator (ICD).... Read more

Hematology

view channel

Blood Donations Screened for Viruses Using Multiplex Assay

A global healthcare company was chosen to partner the Japanese Red Cross (JRC; Tokyo, Japan) for nucleic acid screening of the nation's blood supply. Under the terms of the 7-year agreement, the healthcare company, Grifols (Barcelona, Spain) will provide the JRC with its newest automation platform, the Procleix Panther... Read more

Pathology

view channel

Gene Profile Predicts Risk of Bladder Cancer Recurrence

A genomic study has pinpointed several markers that identify bladder cancer patients at risk of recurrence and that may be indicators of overall survival status. Nearly half of patients with bladder cancer experience recurrences, so reliable predictors of this recurrent phenotype are needed to guide surveillance and treatment.... Read more

Industry News

view channel

Beckman Coulter and hc1.com Enter Strategic Partnership for Innovative Healthcare Cloud System

The diagnostics division of Beckman Coulter (Brea, CA, USA) and hc1.com (Indianapolis, IN, USA) have announced a partnership to bring an innovative healthcare cloud-technology system to clinical laboratories. The system, hc1.com's "Healthcare Relationship Cloud," helps turn large amounts of clinical data into actionable... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.